He-Sheng Luo

1.1k total citations
55 papers, 903 citations indexed

About

He-Sheng Luo is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, He-Sheng Luo has authored 55 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Cancer Research and 12 papers in Epidemiology. Recurrent topics in He-Sheng Luo's work include Liver Disease Diagnosis and Treatment (7 papers), Cancer Research and Treatments (6 papers) and Gastric Cancer Management and Outcomes (5 papers). He-Sheng Luo is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Cancer Research and Treatments (6 papers) and Gastric Cancer Management and Outcomes (5 papers). He-Sheng Luo collaborates with scholars based in China, United States and Switzerland. He-Sheng Luo's co-authors include Jie‐Ping Yu, Baoping Yu, Honggang Yu, Liang Yu, Ximing Xu, Junhua Li, Jin Liu, Eberhard L. Renner, Mei Ye and Bing Xia and has published in prestigious journals such as Hepatology, International Journal of Molecular Sciences and Journal of Hepatology.

In The Last Decade

He-Sheng Luo

54 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
He-Sheng Luo China 17 270 256 244 203 114 55 903
Li H. Gu United States 19 189 0.7× 184 0.7× 507 2.1× 265 1.3× 163 1.4× 33 1.4k
Vincenza Cifarelli United States 19 251 0.9× 216 0.8× 412 1.7× 285 1.4× 200 1.8× 32 1.2k
Elizabeth C. Goode United Kingdom 7 260 1.0× 189 0.7× 436 1.8× 410 2.0× 613 5.4× 9 1.2k
Fawaz Alzaïd France 15 262 1.0× 92 0.4× 383 1.6× 97 0.5× 50 0.4× 45 958
Masahito Ogura Japan 20 302 1.1× 78 0.3× 501 2.1× 225 1.1× 105 0.9× 44 1.2k
Yong‐Hyun Han South Korea 13 289 1.1× 50 0.2× 290 1.2× 137 0.7× 88 0.8× 37 792
Toru Yoshimura Japan 17 349 1.3× 62 0.2× 411 1.7× 162 0.8× 75 0.7× 48 1.1k
Kai Markus Schneider Germany 17 476 1.8× 40 0.2× 347 1.4× 139 0.7× 104 0.9× 47 1.1k
Hong Fu China 16 125 0.5× 74 0.3× 374 1.5× 138 0.7× 138 1.2× 62 958

Countries citing papers authored by He-Sheng Luo

Since Specialization
Citations

This map shows the geographic impact of He-Sheng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He-Sheng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He-Sheng Luo more than expected).

Fields of papers citing papers by He-Sheng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by He-Sheng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He-Sheng Luo. The network helps show where He-Sheng Luo may publish in the future.

Co-authorship network of co-authors of He-Sheng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of He-Sheng Luo. A scholar is included among the top collaborators of He-Sheng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with He-Sheng Luo. He-Sheng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ding, Xiang, et al.. (2020). The prognostic value of long noncoding RNA activated by TGF-β in digestive system cancers. Medicine. 99(30). e21324–e21324. 2 indexed citations
3.
Wang, Ying, Yanxia Li, He-Sheng Luo, & Honggang Yu. (2014). [Efficacy analysis of endoscopic submucosal excavation for gastric gastrointestinal stromal tumors].. PubMed. 17(4). 352–5. 12 indexed citations
4.
Tan, Wei, Honggang Yu, & He-Sheng Luo. (2014). Inhibition of the p38 MAPK pathway sensitizes human gastric cells to doxorubicin treatment in vitro and in vivo. Molecular Medicine Reports. 10(6). 3275–3281. 17 indexed citations
5.
Yu, Shijie, Lei Shen, & He-Sheng Luo. (2013). Endoscopic Submucosal Dissection for Early Gastric Cancer Using Endoscopy With Fuji Intelligent Color Enhancement. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 23(1). e24–e26. 2 indexed citations
6.
Yin, Anning, Yingan Jiang, Xianfeng Zhang, Juan Zhao, & He-Sheng Luo. (2010). Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo. European Journal of Pharmacology. 649(1-3). 120–126. 18 indexed citations
7.
Yu, Baoping, et al.. (2008). Control of gallbladder contractions by cholecystokinin through cholecystokinin-A receptors on gallbladder interstitial cells of cajal. World Journal of Gastroenterology. 14(18). 2882–2882. 29 indexed citations
8.
Zhou, Jing, Lei Wei, Lei Shen, He-Sheng Luo, & Zhixiang Shen. (2008). Primary study of leptin and human hepatocellular carcinoma in vitro. World Journal of Gastroenterology. 14(18). 2900–2900. 20 indexed citations
9.
Luo, He-Sheng, et al.. (2007). [Aberrant expression of EAG1 potassium channels in colorectal cancer].. PubMed. 36(6). 410–1. 1 indexed citations
10.
Cao, Jun, et al.. (2007). [Molecular mechanism of gastrin increasing colon cancer cells' invasion].. PubMed. 87(24). 1704–8. 2 indexed citations
11.
Lv, Peng, et al.. (2006). Effects of Thalidomide on the Expression of Adhesion Molecules in Rat Liver Cirrhosis. Mediators of Inflammation. 2006(1). 93253–93253. 19 indexed citations
12.
Huang, Lei, et al.. (2006). Signal Transduction Pathways Mediating CCK-8S-Induced Gastric Antral Smooth Muscle Contraction. Digestion. 73(4). 249–258. 7 indexed citations
13.
Yu, Jie‐Ping, et al.. (2005). [A study of gastrin-focal adhesion kinase signal pathway in human colon cancer cells].. PubMed. 44(6). 434–7. 1 indexed citations
14.
Liu, Shiquan, et al.. (2005). [Effects of nuclear factor kappaB and transforming growth factor beta1 in the anti-liver fibrosis process using Ginkgo biloba extract].. PubMed. 13(12). 903–7. 5 indexed citations
15.
Jiang, Yingan, et al.. (2004). Effect of antisense oligodeoxynucleotide of telomerase RNA on telomerase activity and cell apoptosis in human colon cancer. World Journal of Gastroenterology. 10(3). 443–443. 6 indexed citations
16.
Yu, Jie‐Ping, et al.. (2004). Expression of estrogen receptor ® in human colorectal cancer. World Journal of Gastroenterology. 10(2). 214–214. 41 indexed citations
17.
Liu, Shaoping, et al.. (2004). Protective effects of Angelica sinensis polysaccharides on acetic acid-induced rat colitis. World Chinese Journal of Digestology. 12(2). 367–367. 1 indexed citations
18.
Wang, Wei, He-Sheng Luo, & Baoping Yu. (2004). Expression of NF-κB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions. World Journal of Gastroenterology. 10(2). 177–177. 38 indexed citations
19.
Dong, Weiguo, et al.. (2003). Role of VEGF and CD44v6 in differentiating benign from malignant ascites. World Journal of Gastroenterology. 9(11). 2596–2596. 28 indexed citations
20.
Luo, He-Sheng, et al.. (2003). [The inhibit effect of berberine on human colon cell line cyclooxygenase-2].. PubMed. 42(8). 558–60. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li H. Gu Breakdown of academic impact, for papers by Vincenza Cifarelli Breakdown of academic impact, for papers by Elizabeth C. Goode Breakdown of academic impact, for papers by Fawaz Alzaïd Breakdown of academic impact, for papers by Masahito Ogura Breakdown of academic impact, for papers by Yong‐Hyun Han Breakdown of academic impact, for papers by Toru Yoshimura Breakdown of academic impact, for papers by Kai Markus Schneider Breakdown of academic impact, for papers by Hong Fu
Rankless by CCL
2026